Professor Ammar Al-Chalabi has been elected as a Fellow of the prestigious Academy for his remarkable contributions to advancing biomedical and health sciences, ground-breaking research discoveries and translating developments into benefits for patients and wider society.
By
NIHR Maudsley BRC at 21 May 2024
Based on the findings of a new study published in Brain, researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London are calling for a complete rethink of the national guidelines surrounding who can access genetic testing for amyotrophic lateral sclerosis (ALS), also called motor neuron disease.
By
NIHR Maudsley BRC at 27 Sep 2022
Today, Monday 21st of June, marks the Global Day of Recognition for AMD/MND. To mark this, we discuss MND research happening at the King's CRF with Lead Research Nurse Theresa and a participant on one of the trials.
By
NIHR Wellcome King's Clinical Research Facility at 17 Jun 2021
A new study of over 3000 people led by King’s College London in collaboration with Lund University, has shown for the first time that a single biomarker can accurately indicate the presence of underlying neurodegeneration in people with cognitive issues.
By
NIHR Maudsley BRC at 7 Jun 2021
Ammar Al-Chalabi, Professor of Neurology and Complex Disease Genetics at Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, has been appointed to the NIHR College of Senior Investigators for 2021 in the 14th round of the Senior Investigator competition. Professor Al-Chalabi is co-lead of the Psychosis and Neuropsychiatry research theme at the National Institute for Health Research (NIHR) Maudsley BRC.
By
NIHR Maudsley BRC at 3 Mar 2021